BDTX Q2 2025 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

$126M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$86,000

Operating Income

-$13M

Net Income

-$11M

EPS (Diluted)

$-0.19

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$166M

Total Liabilities

$34M

Stockholders' Equity

$133M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$86,000	-$86,000	+0.0%
Operating Income	-$13M	-$22M	+39.4%
Net Income	-$11M	-$20M	+47.0%